Health and Healthcare
Major Biotechs See Rising Tide in Short Interest
Published:
Last Updated:
The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside.
As we have said before, FDA rulings can make or break the biotech stocks, and short sellers and mega-bulls often go to war against each other in these companies. After all, if a single failed clinical trial can mean disaster for a stock, then some short sellers can argue for a stock implosion down the road.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Amgen Inc. (NASDAQ: AMGN) saw its short interest decrease to 9.05 million shares from the previous level of 9.18 million. Shares were last seen trading at $220.70, in a 52-week range of $166.30 to $221.38.
Short interest in Biogen Inc. (NASDAQ: BIIB) rose to 4.08 million shares from the previous 3.30 million. The stock recently traded at $294.14, within a 52-week range of $215.78 to $344.00.
Celgene Corp.’s (NASDAQ: CELG) short interest for this settlement date increased to 12.95 million shares from the previous level of 11.82 million. Shares were changing hands at $109.57, in a 52-week range of $58.59 to $109.71.
Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest rise to 14.92 million shares from 13.92 million in the previous period. Shares were trading at $64.64, in a 52-week range of $60.32 to $72.90.
The number of MannKind Corp. (NASDAQ: MNKD) shares short dropped to 39.04 million. The previous reading was 39.55 million. The stock traded at $1.24 a share, in a 52-week range of $0.94 to $2.34.
Alexion Pharmaceuticals Inc.’s (NASDAQ: ALXN) short interest increased to 3.24 million shares from the previous 2.97 million. Shares were trading at $109.01, in a 52-week range of $92.56 to $141.86.
Take Charge of Your Retirement: Find the Right Financial Advisor For You in Minutes (Sponsor)
Retirement planning doesn’t have to feel overwhelming. The key is finding professional guidance—and we’ve made it easier than ever for you to connect with the right financial advisor for your unique needs.
Here’s how it works:
1️ Answer a Few Simple Questions
Tell us a bit about your goals and preferences—it only takes a few minutes!
2️ Get Your Top Advisor Matches
This tool matches you with qualified advisors who specialize in helping people like you achieve financial success.
3️ Choose Your Best Fit
Review their profiles, schedule an introductory meeting, and select the advisor who feels right for you.
Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.